Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...

UBS continues to view Tesla as overvalued despite the company’s expected second-quarter production beat and foreign exchange gains. The firm reiterated its “Sell” rating, citing persistent regulatory ...